Comparison of Purified Plant Polysaccharide (HemoStase) Versus Gelatin-Thrombin Matrix (FloSeal) in Controlling Bleeding During Sinus Surgery: A Randomized Controlled Trial.

Saved in:

Bibliographic Details
Title:	Comparison of Purified Plant Polysaccharide (HemoStase) Versus Gelatin-Thrombin Matrix (FloSeal) in Controlling Bleeding During Sinus Surgery: A Randomized Controlled Trial.
Authors:	Beyea, Jason A. (AUTHOR), Rotenberg, Brian W. (AUTHOR)
Source:	Annals of Otology, Rhinology & Laryngology. Aug2011, Vol. 120 Issue 8, p495-498. 4p. 2 Black and White Photographs, 1 Chart, 1 Graph.
Subjects:	Operative surgery, Intraoperative monitoring, Surgical sponges, Hemorrhage prevention, Therapeutic use of proteins, Sinusitis treatment, Paranasal sinus surgery, Polysaccharides, Thrombin, Comparative studies, Endoscopy, Hemostasis, Health outcome assessment, Surgery, T-test (Statistics), Cutaneous therapeutics, U-statistics, Randomized controlled trials, Treatment effectiveness, Therapeutics
Abstract:	Objectives: Purified plant polysaccharide (HemoStase) is a plant-derived hemostatic agent that has not previously been used in sinus surgery. This study was conducted to evaluate the effectiveness of this novel agent in the control of nasal bleeding during endoscopic sinus surgery. The volume of bleeding during endoscopic sinus surgery was hypothesized to not be statistically significantly different between a control group (gelatin-thrombin matrix; FloSeal) and an experimental group (purified plant polysaccharide; HemoStase). Methods: Eighteen patients with a history of chronic rhinosinusitis in whom maximal medical therapy failed who underwent endoscopic sinus surgery were randomized into one of two groups (control FloSeal group or experimental HemoStase group). In the control group, sites in the nose that were actively bleeding during the operation were controlled with FloSeal. In the experimental group, sites in the nose that were actively bleeding during the operation were controlled with HemoStase. The main outcome measure was total operative blood loss. Blood loss was the sum of blood removed by suction during the surgery (recorded in milliliters) and blood on surgical sponges (weighed and converted to milliliters). Statistical analysis was performed with the i-test and the Mann-Whitney U test. Results: The amounts of blood loss (mean ± SEM) were not significantly different between the FloSeal (262 ± 15 mL) and HemoStase (265 ± 33 mL) groups (p = 0.93). Conclusions: The results of this study demonstrate the use of a novel product for the control of intraoperative bleeding during endoscopic sinus surgery. [ABSTRACT FROM AUTHOR]
	Copyright of Annals of Otology, Rhinology & Laryngology is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	Psychology and Behavioral Sciences Collection

Description
Abstract:	Objectives: Purified plant polysaccharide (HemoStase) is a plant-derived hemostatic agent that has not previously been used in sinus surgery. This study was conducted to evaluate the effectiveness of this novel agent in the control of nasal bleeding during endoscopic sinus surgery. The volume of bleeding during endoscopic sinus surgery was hypothesized to not be statistically significantly different between a control group (gelatin-thrombin matrix; FloSeal) and an experimental group (purified plant polysaccharide; HemoStase). Methods: Eighteen patients with a history of chronic rhinosinusitis in whom maximal medical therapy failed who underwent endoscopic sinus surgery were randomized into one of two groups (control FloSeal group or experimental HemoStase group). In the control group, sites in the nose that were actively bleeding during the operation were controlled with FloSeal. In the experimental group, sites in the nose that were actively bleeding during the operation were controlled with HemoStase. The main outcome measure was total operative blood loss. Blood loss was the sum of blood removed by suction during the surgery (recorded in milliliters) and blood on surgical sponges (weighed and converted to milliliters). Statistical analysis was performed with the i-test and the Mann-Whitney U test. Results: The amounts of blood loss (mean ± SEM) were not significantly different between the FloSeal (262 ± 15 mL) and HemoStase (265 ± 33 mL) groups (p = 0.93). Conclusions: The results of this study demonstrate the use of a novel product for the control of intraoperative bleeding during endoscopic sinus surgery. [ABSTRACT FROM AUTHOR]
ISSN:	00034894
DOI:	10.1177/000348941112000801